EN

What should I ask my GP about GLP-1 medicines?

Answer a few questions and get a printable visit sheet for your GP or a specialist: what to bring, questions for your situation, how to check an online service, and when to call 000.

Takes about 2 minutes Nothing you type leaves your device Every question cites its source
Step 1 of 9Who it's for
Who is this visit sheet for?

We'll write the sheet in the right voice: "my" for you, "their" for someone else.

Age (optional)
Sex (optional; sets the pregnancy questions)
What's the main reason for the visit?

Pick the closest one. It changes which questions come first.

Do you have any of these health conditions?

Tick any that apply and skip the rest. Each one you tick adds a question for the doctor to your sheet.

Linked to weight or sugar
Need extra care with these medicines
Personal or family history
Which medicines do you take now?

Some of these change what the prescriber needs to plan. Tick all that apply.

Could you be pregnant, or are you planning a baby?

These medicines aren't used in pregnancy, and one affects the pill. This step is skipped if you chose "Man".

Which tests have you had in the last 3 months?

Tick the ones with a result you can show, for example on a printout or in an app. The sheet asks about the rest.

What worries you most?

Pick as many as you like. Each adds a sourced question.

Height, weight and waist

Optional. If you add them, the sheet shows BMI against the Australian cut-offs, and your waist against the cut-offs for women and men. Skip this if you'd rather be measured at the appointment.

Height
Weight
Waist (halfway between your lowest rib and the top of your hip bone, after breathing out)
Ethnic background (optional; sets which Australian cut-offs apply)
Anything else the prescriber should know?

Optional. For example: past attempts at losing weight, side effects so far, or a surgery date. It goes into the "About" box, and you can edit it on the sheet too.

Next, you'll see the sheet. You can tick items, edit any line, add your own questions, then print it, save it as a PDF or email it to yourself.

Private by design: the sheet is built in your browser. Nothing is sent or stored unless you choose to email it to yourself, and nothing goes in the link. Privacy notice

Your visit sheet is ready

Tap any line in "About" or any question to change the words. Remove questions with ×, or add your own. Ticks print too.

What this means

What this doesn't mean

  • It isn't a yes or a no. No tool can tell whether a GLP-1 medicine suits someone. A prescriber decides that after a history, a check-up and tests.
  • It isn't every question. It covers the common ones and those your answers point to. Your GP may ask about things not listed here.
  • Don't change any medicine on your own. The dose questions are for the prescriber to answer, not for you to act on before the visit.

Why each question is on your sheet

The rule behind each question for your situation, with its source. The numbers match the sources at the foot of the sheet. All checked 12 Oct 2026.

    Read before the visit

    How this works

    You answer up to 9 short questions. Only the first one is needed. The tool then picks questions from a fixed list, and every question is tied to a source: an Australian or US product label, TGA safety advice, Australian guidance or the Medical Board's telehealth rules.2,3,5,1,6

    Eight core questions go on every sheet. Your answers add more. For example, insulin or a sulfonylurea (such as gliclazide) adds a question about low blood sugar, because the Ozempic label warns about low sugar (hypos) with that mix.3

    If you add height and weight, the sheet shows BMI against the Australian cut-offs, including the lower ones for Asian, Aboriginal and Torres Strait Islander people. A waist measurement is compared with the cut-offs for women and men.1 These numbers describe weight. They are not a threshold for medicine.

    The "Check your provider" box uses the Medical Board's telehealth guidelines and Ahpra's advice on virtual care.6,7 The red box lists the symptoms that need 000, and how to report a side effect to the TGA.12,9 We don't show or compare prices.

    What this can't tell you

    • Whether a GLP-1 medicine suits you, or which one. That's for a prescriber who has checked you.
    • Anything about your dose. The tool never suggests one.
    • What it will cost, or whether the PBS covers your situation. The PBS subsidises GLP-1 medicines only for type 2 diabetes, with criteria.13

    Questions people ask

    Is anything I type saved or sent anywhere?

    No. The sheet is built inside your browser. Nothing you type is sent to us or stored, and there is no link that contains your answers. Only if you choose "Email it to me" do we pass the sheet and your address to our email service once, to deliver it.

    Can I make a sheet for my mother or father?

    Yes. Choose "A family member" on the first screen and the sheet is written about them.

    Can my GP prescribe these medicines?

    Yes. GLP-1 medicines are prescription-only (Schedule 4), and we found no rule limiting them to specialists.15 On the PBS they are subsidised only for type 2 diabetes, with criteria, and the first script needs an authority approval.13

    Why does it ask about the contraceptive pill?

    Tirzepatide (Mounjaro) can make the pill less reliable. Its US label advises a non-pill method, or adding a barrier method such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase,4 and the TGA updated the Australian Mounjaro contraception advice in December 2025.5

    I'm already taking a GLP-1. Is this useful for me?

    Yes. Choose "Already taking one" and the sheet becomes a review: who prescribed it and how they assessed you, your dose, whether your product could be a fake, and whether it's working well enough to continue.6,10,11

    How do I report a side effect?

    Report it to the TGA online, or ask your GP or pharmacist to report it for you.9 The TGA also wants to hear about products you think are fake.10

    Sources

    1. Australian Diabetes Society, with ANZOS, ANZMOSS and the RACGP. Australian Obesity Management Algorithm, July 2024: BMI and waist cut-offs (Table 2), weight-loss targets and long-term use. diabetessociety.com.au. Checked 12 Oct 2026.
    2. Novo Nordisk. Wegovy Product Information (Australia), revised 22 June 2026: sections 4.1 and 4.2. medsinfo.com.au. Checked 12 Oct 2026.
    3. Novo Nordisk. Ozempic (semaglutide) US prescribing information, revised May 2026: sections 5, 7, 8.3. PDF. Checked 12 Oct 2026.
    4. Eli Lilly. Mounjaro (tirzepatide) US prescribing information, revised August 2026: section 7 (oral contraceptives). PDF. Checked 12 Oct 2026.
    5. Therapeutic Goods Administration. Safety updates on GLP-1 medicines: updated contraception advice for Mounjaro (1 December 2025); new warnings for anaesthesia or deep sedation (3 June 2025); rare but severe eye disorders (23 July 2026). tga.gov.au. Checked 12 Oct 2026.
    6. Medical Board of Australia. Guidelines: telehealth consultations with patients, in effect 1 September 2023 ("Prescribing or providing healthcare for a patient without a real-time direct consultation, whether in-person, via video or telephone, is not good practice"). medicalboard.gov.au. Checked 12 Oct 2026.
    7. Ahpra. Information for practitioners who provide virtual care, updated 7 October 2025 ("The Boards do not consider an online chat to be a synchronous (in real time) consultation"). ahpra.gov.au. Checked 12 Oct 2026.
    8. Therapeutic Goods Administration. Update on GLP-1 receptor agonists: pharmacy compounding changes (no compounding from 1 October 2024), media release 18 June 2024. tga.gov.au. Checked 12 Oct 2026.
    9. Therapeutic Goods Administration. Reporting adverse events: for consumers, updated 2 September 2026. tga.gov.au. Checked 12 Oct 2026.
    10. Therapeutic Goods Administration. Safety alert: counterfeit weight-loss products claiming to contain GLP-1, 2 March 2026. tga.gov.au. Checked 12 Oct 2026.
    11. Therapeutic Goods Administration. Ozempic (semaglutide) safety collection, including counterfeit pens detected in September 2024 and April 2025. tga.gov.au. Checked 12 Oct 2026.
    12. healthdirect Australia. How healthdirect can help you: call triple zero (000) for an ambulance; helpline 1800 022 222, 24/7. healthdirect.gov.au. Checked 12 Oct 2026.
    13. Pharmaceutical Benefits Scheme. Type 2 diabetes medicines pathway, at 1 December 2024 (GLP-1 after an SGLT2 inhibitor; authority for the first script). pbs.gov.au. Checked 12 Oct 2026.
    14. Eli Lilly. Mounjaro Product Information (Australia), vA14.0, revised 2 October 2026: section 4.1 and storage. medsinfo.com.au. Checked 12 Oct 2026.
    15. healthdirect Australia. Wegovy: "Schedule 4: Prescription Only Medicine". healthdirect.gov.au. Checked 12 Oct 2026.

    The sheet itself cites up to 30 more sources, listed at its foot. Last checked 12 Oct 2026 · Next review due Jan 2027

    How this tool was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to your GP before starting, stopping or changing any medicine. In an emergency, call 000; if you're not sure, call healthdirect on 1800 022 222. How we write